Literature DB >> 2463620

Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.

M Noda1, H Kitayama, T Matsuzaki, Y Sugimoto, H Okayama, R H Bassin, Y Ikawa.   

Abstract

Seven morphologically nontransformed (flat) revertants with reduced tumorigenicity in vivo have been isolated from populations of Kirsten sarcoma virus-transformed NIH 3T3 cells transfected with a cDNA expression library of normal human fibroblasts. Each revertant harbors 1-10 recombinant plasmids per cell and retains a rescuable transforming virus as well as high level expression of v-Ki-ras-specific RNA and the viral oncogene product, p21v-Ki-ras. Transformed phenotypes are suppressed in cell hybrids generated by fusing each revertant to v-Ki-ras-transformed NIH 3T3 cells. From two of the revertant lines, plasmids capable of giving rise to flat secondary transfectants have been recovered. Thus, in some, if not all, of the revertants, transfected cDNAs seem to be responsible for the suppression of specific transformed phenotypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463620      PMCID: PMC286424          DOI: 10.1073/pnas.86.1.162

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Nonreciprocal exchanges of information between DNA duplexes coinjected into mammalian cell nuclei.

Authors:  K R Folger; K Thomas; M R Capecchi
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

2.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes.

Authors:  H Zarbl; J Latreille; P Jolicoeur
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

4.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes.

Authors:  H L Cooper; N Feuerstein; M Noda; R H Bassin
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

Review 6.  The approaching era of the tumor suppressor genes.

Authors:  G Klein
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

7.  Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.

Authors:  D S Salomon; J A Zwiebel; M Noda; R H Bassin
Journal:  J Cell Physiol       Date:  1984-10       Impact factor: 6.384

8.  Reduced protein kinase C activity in a ras-resistant cell line derived from Ki-MSV transformed cells.

Authors:  T Kamata; N F Sullivan; M W Wooten
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

9.  Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes.

Authors:  M Oshimura; T M Gilmer; J C Barrett
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

10.  Selective packaging of human growth hormone into synaptic vesicles in a rat neuronal (PC12) cell line.

Authors:  E S Schweitzer; R B Kelly
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  35 in total

1.  Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.

Authors:  Yue Zhang; Shaoqiang Cheng; Guoqiang Zhang; Wenjie Ma; Yang Liu; Rui Zhao; Qingyuan Zhang; Da Pang
Journal:  Cancer Sci       Date:  2012-04-19       Impact factor: 6.716

2.  Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation.

Authors:  M L Cutler; R H Bassin; L Zanoni; N Talbot
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

3.  Development of a highly efficient expression cDNA cloning system: application to oncogene isolation.

Authors:  T Miki; T P Fleming; M Crescenzi; C J Molloy; S B Blam; S H Reynolds; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 4.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

5.  Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation.

Authors:  L Masuelli; M L Cutler
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression.

Authors:  Yusuke Higashi; Srinivas Mummidi; Sergiy Sukhanov; Tadashi Yoshida; Makoto Noda; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2019-02-01       Impact factor: 4.315

7.  Translationally controlled tumor protein is a target of tumor reversion.

Authors:  Marcel Tuynder; Giusy Fiucci; Sylvie Prieur; Alexandra Lespagnol; Anne Géant; Séverine Beaucourt; Dominique Duflaut; Stéphanie Besse; Laurent Susini; Jean Cavarelli; Dino Moras; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

8.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

9.  Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria.

Authors:  C J Kho; H Zarbl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 10.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.